Individuals with congenital IL-6R deficiency experience recurrent bacterial infections (30), prompting concerns among clinical experts that IL-6R inhibition may compromise the body’s ability to resist pathogens, leading to severe infections, which is a high risk for patients with cachexia. This evidence concerns the gene IL6R and Cachexia.